openPR Logo
Press release

Peptide Cancer Vaccine Market Emerging Trends And Technology 2026 TapImmune, Merck, Galena Biopharma, Antigen Express, VAXON Biotech, BioLife Science

02-12-2019 11:52 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Peptide Cancer Vaccine Market

Peptide Cancer Vaccine Market

Peptide cancer vaccines aids to elicit and expand tumor-specific T-cells capable of controlling or eradicating tumor. This vaccine consists of one or more short or long amino acid sequences as tumor antigens, combined with vaccine adjuvant. In the recent past, results of clinical trials performed using peptide cancer vaccine had exhibited negative outcomes. So, researchers in the peptide vaccine have considered this as outdated therapy and declared it as no longer viable for cancer treatment. However, increasing progress in understanding critical role of immune adjuvants, modes of vaccine administration, and T cell dynamics has led to re-emergence of this approach for treating malignant disorders.

Furthermore, advantages involved in the preparation and usage of peptide vaccine are easy to synthesize, cost-effective, easy to prepare, and its application in clinical practice, flexibility in changing antigen, and lower risk of antigen-induced anaphylaxis are expected to foster growth of the peptide cancer vaccine market in the near future. Therefore, owing to these advantages, manufacturers are focusing on research, to develop peptide cancer vaccines. For instance, in April 2018, Boston Biomedical, Inc. involved in next generation cancer therapeutics, initiated dosing of the first patient in each of two clinical studies to evaluate the results of its affectability by using DSP-7888, an investigational cancer peptide vaccine.

For In depth Information Get FREE Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/1634

Global Peptide Cancer Vaccine Market - Competitive Analysis

-TapImmune
-Merck
-BrightPath Biotherapeutics
-Sellas
-BioLife Science
-Boston Biomedical
-VAXON Biotech
-Lytix Biopharma
-ISA Pharmaceuticals
-Generex Biotechnology
-OncoTherapy Science
-Enzo Life Science
-Antigen Express
-Immatics Biotechnologies
-Immatics
-Immune Design
-Immunomedics
-Galena Biopharma
-Generex Biotechnology Corporation
-Ultimovacs

Global Peptide Cancer Vaccine Market - Taxonomy:

By Pipeline Phase:
-Research
-Preclinical
-Phase-I
-Phase-I/II
-Phase-II
-Phase-III

By Application:
-Colorectal Cancer
-Lung Cancer
-Pancreatic Cancer
-Gastric Cancer
-Prostate Cancer
-Breast Cancer

By Region:
-North America
-Latin America
-Europe
-Asia Pacific
-Middle East
-Africa

Global Peptide Cancer Vaccine Market Dynamics

Increasing prevalence of cancer and failure of conventional methods to treat the disease effectively have led to increasing demand for new immunotherapy-based therapy such as peptide vaccine. According to a National Cancer Institute, 2016, in the U.S., it was estimated that 16.8 million new cases of cancer were diagnosed with an approximate 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024. Furthermore, the World Health Organization (WHO) reported around 14 million cases of cancer and 8.2 million deaths caused by the disease in 2012. Among these, the common cases pertained to lung, colorectal, prostate, cervical, and breast cancer, which significantly has increased demand for peptide vaccines, in turn aiding in growth of the global peptide cancer vaccine market.

Furthermore, to cater to increasing demand for vaccines, manufacturers are also involved in mergers and acquisitions and new product launches in the peptide cancer vaccine market. For instance, in May 2018, Merck & Co. invested US$ 125 Million in Moderna Therapeutics. This expansion included partnering on mRNA-5671, Moderna’s mRNA KRAS cancer vaccine, and other shared antigen mRNA cancer vaccines. This vaccine includes an mRNA for four most commonly found KRAS mutations, which according to Moderna will cover most of the mutation that occur in non-small-cell lung cancer (NSCLC), colorectal cancer, and pancreatic cancer. In November 2017, Moderna launched the Phase I KEYNOTE-603 study of mRNA-4157, an mRNA-based personalized cancer vaccine being developed with Merck & Co., through a US$ 100-million-plus mRNA partnership.

Furthermore, in November 2017, TapImmune Inc., a clinical-stage immune-oncology company with ongoing clinical trials in breast and ovarian cancer, announced that the company has enrolled the final patient in randomized Phase 2 clinical study for its novel T-cell vaccine candidate TPIV200 for treating triple-negative breast cancer (TNBC). More such clinical trials for peptide cancer vaccines are expected to boost growth of the global peptide cancer vaccine market in the near future.

For More Details On this Report: https://www.coherentmarketinsights.com/ongoing-insight/peptide-cancer-vaccine-market-1634

Global Peptide Cancer Vaccine Market - Regional Insights

North America market accounted for the largest share in the global peptide cancer vaccine market, followed by Europe market in 2016. This is attributed to presence of a high number of top pharmaceutical and biotech companies in this region, such as, Pfizer, Inc., Novartis, Merck, GlaxoSmithKline, Roche and many more. Moreover, the rising prevalence of cancer is also expected to foster the market of peptide cancer vaccine market in the near future. According to a National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer are diagnosed in the U.S., with an approximate 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024.

Moreover, several pharmaceutical and biotechnological companies are focusing on expanding in Asia Pacific region to maximize the value on their R&D efforts as the Asia Pacific region provides better access to patients for clinical trials, and also provides lower cost operational efficiencies. Increasing government investment in research and development also fosters growth of the global peptide cancer vaccine market in Asia Pacific. For instance, in March 2011, the Korean government participated in the Korean National Enterprise for Clinical Trials, to advance the country’s infrastructure for conducting clinical trials, which is expected to launch new peptide cancer vaccine in the market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Cancer Vaccine Market Emerging Trends And Technology 2026 TapImmune, Merck, Galena Biopharma, Antigen Express, VAXON Biotech, BioLife Science here

News-ID: 1580420 • Views:

More Releases from Coherent Market Insights

Lithium Hydride Market Size, Share, Growth, Industry Analysis, Forecast By 2024-2031 | Merck KGaA., Albemarle Corporation
Lithium Hydride Market Size, Share, Growth, Industry Analysis, Forecast By 2024- …
Global Lithium Hydride Market Growing Demand and Growth Opportunity 2024-2031: The Latest Report, titled "Lithium Hydride Market" Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The Lithium Hydride market has been growing significantly in recent
Frankincense Extracts Market Overview by Increasing Demands and Sales By 2024-2031 | De Monchy Aromatics Limited, AOS Products Private Limited
Frankincense Extracts Market Overview by Increasing Demands and Sales By 2024-20 …
Global Frankincense Extracts Market Growing Demand and Growth Opportunity 2024-2031: The Latest Report, titled "Frankincense Extracts Market" Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The Frankincense Extracts market has been growing significantly in recent
Disposable Slippers Market Valuation 2024: Size, Share, Outlook, Trends & Forecast Till 2031 | Haon Group, Dispowear Sterite Company
Disposable Slippers Market Valuation 2024: Size, Share, Outlook, Trends & Foreca …
Global Disposable Slippers Market Growing Demand and Growth Opportunity 2024-2031: The Latest Report, titled "Disposable Slippers Market" Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The Disposable Slippers market has been growing significantly in recent
Vegetable Parchment Paper Market Will Exhibit an Impressive Expansion by 2024-2031 | Reynolds KITCHENS Parchment Paper with SmartGrid
Vegetable Parchment Paper Market Will Exhibit an Impressive Expansion by 2024-20 …
Global Vegetable Parchment Paper Market Growing Demand and Growth Opportunity 2024-2031: The Latest Report, titled "Vegetable Parchment Paper Market" Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The Vegetable Parchment Paper market has been growing

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top